Cargando…

MedSafer to Support Deprescribing for Residents of Long-Term Care: a Mixed-Methods Study

BACKGROUND: Polypharmacy is prevalent in long-term care homes (LTCH) and increases the risk of adverse drug events. Feasible and effective deprescribing interventions applicable in the LTCH environment are needed. METHODS: We performed a mixed methods study to evaluate the feasibility, applicability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perri, Giulia-Anna, Bortolussi-Courval, Émilie, Brinton, Christopher D., Berall, Anna, Santiago, Anna Theresa, Morcos, Mareiz, Lee, Todd C., McDonald, Emily G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Canadian Geriatrics Society 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156423/ https://www.ncbi.nlm.nih.gov/pubmed/35747414 http://dx.doi.org/10.5770/cgj.25.545

Ejemplares similares

Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial
por: Moryousef, Joseph, et al.
Publicado: (2022)

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial
por: McDonald, Emily G., et al.
Publicado: (2022)

Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial
por: Nadeau, Marc-Eric, et al.
Publicado: (2021)

Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study
por: Bortolussi-Courval, Émilie, et al.
Publicado: (2023)

Medsafe: potentially fatal adverse effects with Miracle Mineral Solution
Publicado: (2020)

NZ's Medsafe reminder: pericarditis/myocarditis may occur after Comirnaty vaccination
Publicado: (2022)

Incentivizing an exodus: The implications of recruiting nurses from low-middle income countries to high-income countries
por: Bortolussi-Courval, Émilie, et al.
Publicado: (2023)

Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-analysis
por: Hanula, Ryan, et al.
Publicado: (2023)

Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications
por: Ross, Sydney B., et al.
Publicado: (2022)

Deprescribing Blood Pressure Treatment in VA Long-Term Care Residents
por: Odden, Michelle, et al.
Publicado: (2021)

Deprescribing Blood Pressure Treatment in VA Long-Term Care Residents
por: Odden, Michelle, et al.
Publicado: (2021)

Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework
por: Thorpe, Carolyn, et al.
Publicado: (2023)

A Novel Instrument for Caregivers in Managing Neuropsychiatric Symptoms of Dementia: Baycrest Quick-Response Caregiver Tool(TM)
por: Madan, Robert, et al.
Publicado: (2022)

Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden
por: Bolmsjö, Beata Borgström, et al.
Publicado: (2016)

The potential for deprescribing in care home residents with Type 2 diabetes
por: Andreassen, Lillan Mo, et al.
Publicado: (2016)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Translation and cultural adaptation of MedStopper®—A web-based decision aid for deprescribing in older adults: A protocol
por: Monteiro, Luís, et al.
Publicado: (2023)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
por: Vasilevskis, Eduard E., et al.
Publicado: (2019)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study
por: Visser, Anne G. R., et al.
Publicado: (2021)

Perspectives on Deprescribing in long-term care: qualitative findings from nurses, aides, residents, and proxies
por: Little, Milta O., et al.
Publicado: (2023)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Deprescribing in Hospice Patients: Discontinuing Aspirin, Multivitamins, and Statins
por: Low, Cari E., et al.
Publicado: (2021)

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023)

What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals
por: Turner, Justin P, et al.
Publicado: (2016)

Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial
por: Williams, Jerome, et al.
Publicado: (2022)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study
por: Etherton-Beer, Christopher, et al.
Publicado: (2023)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Deprescribing: Fashion Accessory or Fig Leaf?
por: Zermansky, Arnold G.
Publicado: (2019)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9t4fdgnhhgdnld0gvcmu9aqi07